Related Experiment Video
Updated: Mar 11, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
On a FOX hunt: functions of FOX transcriptional regulators in bladder cancer
Hironobu Yamashita1, Vasty Osei Amponsa1, Joshua I Warrick1
1Department of Pathology, Pennsylvania State University College of Medicine, 500 University Drive, Hershey, Pennsylvania 17033, USA.
Abstract:
Genomic and transcriptional studies have identified discrete molecular subtypes of bladder cancer. These observations could be the starting point to identify new treatments. Several members of the forkhead box (FOX) superfamily of transcription factors have been found to be differentially expressed in the different bladder cancer subtypes. In addition, the FOXA protein family are key regulators of embryonic bladder development and patterning. Both experimental and clinical data support a role for FOXA1 and FOXA2 in urothelial carcinoma. FOXA1 is expressed in embryonic and adult urothelium and its expression is altered in urothelial carcinomas and across disparate molecular bladder cancer subtypes. FOXA2 is normally absent from the adult urothelium, but developmental studies identified FOXA2 as a marker of a transient urothelial progenitor cell population during bladder development. Studies also implicate FOXA2 in bladder cancer and several other FOX proteins might be involved in development and/or progression of this disease; for example, FOXA1 and FOXO3A have been associated with clinical patient outcomes. Future studies should investigate to what extent and by which mechanisms FOX proteins might be directly involved in bladder cancer pathogenesis and treatment responses.
Insights
Forkhead box (FOX) proteins are differentially expressed in bladder cancer subtypes and may play roles in disease development and treatment. Further research is needed to understand their precise involvement in urothelial carcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Genomic and transcriptional studies reveal distinct molecular subtypes of bladder cancer.
- The forkhead box (FOX) superfamily of transcription factors shows differential expression across these subtypes.
- FOXA proteins are crucial for embryonic bladder development and patterning.
Purpose of the Study:
- To investigate the role of FOXA1 and FOXA2 in urothelial carcinoma.
- To explore the involvement of other FOX proteins in bladder cancer development and progression.
- To identify potential therapeutic targets within the FOX protein family.
Main Methods:
- Analysis of genomic and transcriptional data from bladder cancer subtypes.
- Review of experimental and clinical data on FOXA1 and FOXA2 expression.
- Examination of developmental studies implicating FOXA2 in urothelial progenitor cells.
Main Results:
- FOXA1 expression is altered in urothelial carcinomas and varies across molecular bladder cancer subtypes.
- FOXA2, typically absent in adult urothelium, is identified as a marker of transient progenitor cells during development.
- FOXA1 and FOXO3A are associated with clinical patient outcomes in bladder cancer.
Conclusions:
- Both FOXA1 and FOXA2 have implicated roles in urothelial carcinoma.
- Other FOX proteins may also contribute to bladder cancer pathogenesis.
- Further investigation into the mechanisms and therapeutic potential of FOX proteins in bladder cancer is warranted.
More Related Videos
06:01Expression of Transgenes in Native Bladder Urothelium Using Adenovirus-Mediated Transduction
Published on: October 6, 2022
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Related Concept Videos
Master Transcription Regulators
Regulation of Angiogenesis and Blood Supply
General Transcription Factors
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Co-activators and Co-repressors